Third Rock Ventures V, L.P. has filed 15 insider transactions across 2 companies since June 2024.
Most recent transaction: a sale of 133618 shares of Rapport Therapeutics, Inc. ($RAPP) on May 11, 2026.
Activity breakdown: 2 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | S | Common Stock | 133618 | $40.24 | 7,268,315.0000 | 47,661,138 | 1.81% | 0.28% |
| May 8, 2026 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | S | Common Stock | 5018 | $40.31 | 7,401,933.0000 | 47,661,138 | 0.07% | 0.01% |
| May 7, 2026 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | S | Common Stock | 271495 | $40.12 | 7,406,951.0000 | 47,661,138 | 3.54% | 0.57% |
| April 17, 2026 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | S | Common Stock | 426005 | $40.32 | 7,678,446.0000 | 47,661,138 | 5.26% | 0.89% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | Third Rock Ventures V, L.P. | Not found | C | Series A Preferred Stock | 41250000 | $0.00 | 0.0000 | 2,443,678 | 100.00% | 100.00% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | Third Rock Ventures V, L.P. | Not found | C | Series B Preferred Stock | 24737017 | $0.00 | 0.0000 | 2,443,678 | 100.00% | 100.00% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | Third Rock Ventures V, L.P. | Not found | C | Common Stock | 4790773 | $0.00 | 8,997,547.0000 | 2,443,678 | 113.88% | 100.00% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | Third Rock Ventures V, L.P. | Not found | C | Common Stock | 2872956 | $0.00 | 9,088,547.0000 | 2,443,678 | 46.22% | 100.00% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | Third Rock Ventures V, L.P. | Not found | P | Common Stock | 370500 | $18.00 | 9,368,047.0000 | 2,443,678 | 4.12% | 15.16% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | Third Rock Ventures V, L.P. | Not found | P | Common Stock | 279500 | $18.00 | 9,368,047.0000 | 2,443,678 | 3.08% | 11.44% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | C | Series B Preferred Stock | 298103 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | C | Series A Preferred Stock | 8000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | C | Series A Preferred Stock | 56091177 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | C | Common Stock | 969218 | $0.00 | 8,104,451.0000 | 0 | 13.58% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | Third Rock Ventures V, L.P. | Not found | C | Common Stock | 6551449 | $0.00 | 8,104,451.0000 | 0 | 421.86% | 0.00% |